Antibiotic Resistance Market Players, Trends, Segmentation Analysis and Forecast to 2030

Antibiotic Resistance Market

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic.

Antibiotic resistance market is expected to reach USD 17387.01 million at CAGR of 5.34% during the forecast period of 2020 to 2030

The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance

Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Antibiotic Resistance Market Players are Achaogen, Inc. (US), MELINTA THERAPEUTICS, INC. (US), Nabriva Therapeutics plc (Ireland), PARATEK therapeutics (US), Seres Therapeutics (US), Theravance Biopharma (UK), Tetraphase Pharmaceuticals (US), Basilea Pharmaceutica Ltd. (Switzerland), Entasis Therapeutics (US), NEMESIS BIOSCIENCE LTD (UK), Procarta Biosystems (England), and Allecra Therapeutics (US)

Segment Analysis

The Global Antibiotic Resistance Market has been Segmented Based on Drug Class, Disease, Pathogen, and End User.

The market, based on drug class, has been divided into cephalosporins, Combination therapies, tetracyclines, lipoglycopeptides, oxazolidinones, and others. The combination therapies segment is likely to be the largest growth during the review period due to the increased usage of these therapies for gram-negative infections. Additionally, it has minimal treatment options available with the increasing demand for antibiotic resistance, thus driving the growth of this segment.

The global antibiotic resistance market has been bifurcated, based on disease, into complicated urinary tract infections, bloodstream infections, complicated intra-abdominal infections, clostridium difficile infections, acute bacterial and skin structure infections, hospital-acquired bacterial pneumonia/ventilator, community-acquired bacterial pneumonia, and others. The complicated urinary tract infections segment is expected to hold the majority share of the market as urinary tract infections (UTIs) are one of the most common types of infections. Additionally, there were around 1,045 patients affected by UTI.

The global antibiotic resistance market has been segmented based on pathogen into staphylococcus aureus, streptococcus pneumoniae, antibiotic resistant bacteria, acinetobacter, enterococcus, Hemophilus influenzae, pseudomonas aeruginosa, clostridium difficile, K. pneumoniae, campylobacter, and others. K. pneumoniae is expected to be the fastest segment owing to the increasing K. pneumoniae. Moreover, there were around 212,500 infection cases per year and about 70 deaths every year which would eventually drive the growth of the antibiotic market in this segment.

The end user segment of the antibiotic resistance market includes hospitals & clinics, research organizations, and others. The hospitals & clinics segment is expected to hold the largest share of the market as the majority of treatments and procedures are carried out in hospitals, which ultimately increases the usage of antibiotic resistance drugs in the antibiotic resistance market. As a result, this drives the growth of the antibiotic resistance market.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising growth in the pharmaceutical sector. The antibiotic resistance market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European antibiotic resistance market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The antibiotic resistance market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing healthcare expenditure has boosted the growth of the antibiotic resistance market; the market in Asia-Pacific is expected to be the fastest-growing. The antibiotic resistance market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Atrial Fibrillation Market Players, Size, share, Business Opportunity and Global Forecast to 2030

Atrial Fibrillation Market

Atrial fibrillation is a disorder of the pace or the rhythm of the heart. It is caused by unsystematic electrical activity in the atria of the heart, which causes rapid stimulus of the ventricles, leading to an irregular heartbeat. Numerous factors such as advancements in minimally invasive surgeries to treat atrial fibrillation, appropriate and timely intervention of the healthcare delivery systems, and increased incidence rates of the risk factors are expected to drive the growth of the market during the forecast period.

Atrial fibrillation market is expected to reach USD 3,470.85 Million at a CAGR 13.30% during the forecast period of 2022-2030

The global atrial fibrillation market is currently dominated by many market players. The key players in the market are engaged in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2017, Abbott completed the acquisition of St. Jude Medical, Inc. St. Jude Medical's strong positions in fast-growing areas such as atrial fibrillation, heart failure, structural heart and chronic pain balance Abbott's leading positions in coronary interventions and mitral valve disease and will further create a strong and diverse product portfolio.

Major Key Players:

Some of the Atrial Fibrillation Market Players are Medtronic Plc, Johnson & Johnson Services, Inc., Abbott, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure, Inc., CardioFocus, Osypka AG, Siemens AG, Biosense Webster, Inc., Sichuan Jinjiang Electronic Science and Technology Co., Ltd., CathRx Ltd., and Vanguard AG.

Segment Analysis

The global atrial fibrillation market has been segmented into type, treatment, and end-user.

The atrial fibrillation devices market, on the basis of type, has been segmented into paroxysmal atrial fibrillation, persistent atrial fibrillation, and permanent atrial fibrillation.

The permanent type of atrial fibrillation is anticipated to hold the largest share as it is the most common type of AFib with a high occurrence rate. The persistent atrial fibrillation segment is estimated to be the fastest growing owing to increased recurrence rates in patients.

The market, on the basis of treatment, has been segmented into medications, non-surgical procedures, and surgical procedures.

The market, based on medications, has been segmented blood thinners, rate controllers, and rhythm controllers.

The market, based on non-surgical procedures, has been segmented into electrical cardioversion and catheter ablation.

The market, based on surgical procedures, has been segmented into pacemaker implantation and open-heart maze procedure.

Regional Analysis

The market in the Americas is expected to dominate the global atrial fibrillation market during the forecast period due to the escalation in the adoption of advanced technologies and procedures for the treatment of atrial fibrillation, and well-developed healthcare infrastructure. According to the Centers for Disease Control and Prevention in 2017, an estimated 2.7–6.1 million people in the United States have atrial fibrillation (AFib). The European market is expected to be the second-largest due to government funding and support of the healthcare sector. Also, many companies are setting up their research and development centers in this region, which will boost the market growth in this region. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing disposable income, and huge population susceptible to cardiovascular diseases. The market in the Middle East & Africa is likely to account for the smallest share of the global atrial fibrillation market.  

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Body Composition Analyzers Market Analysis, Industry Demand, Regional Trend and Business Prospect by Forecast to 2030

Body Composition Analyzers Market

The Body Composition Analyzers Market is expected to reach USD 670.48 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.

Body composition contains three major compound water, fat mass, and muscle mass. Body composition analyzing devices are used for measuring the ratio of water, fat, and muscles in the body and recording their respective values at the point of the investigation. Body composition analyzers provide aid in analysis of increased variations in the body structure for a specific period. It has applications medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc.

The growth of the global body composition analyzers market is determined by numerous factors such as increasing prevalence of metabolic disorders, technological advancements in the healthcare industry, and rising obese population. However, the increasing cost of body composition analyzers and inconsistent results are likely to hamper the growth of the global body composition analyzers market during the forecast period.

Several market players currently dominate the global body composition analyzers market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Key Body Composition Analyzers Market Players are GE Healthcare Inc., Hologic Inc., Beurer GmbH, Inbody Co. Ltd., Bodystat, Cosmed S.R.L,  Jawon Medical Co., Ltd, Maltron International Ltd., Omron Healthcare Inc., Seca GmbH & Co. Kg., Tanita Corporation, AccuFitness, LLC,  and others.

Segment Analysis

The global body composition analyzers has been segmented based on best body composition analyzer product type, mobility, and end user.

The market, based on product type, has been divided into bioimpedance analyzer, skinfold calipers, dual-energy X-Ray absorptiometry, hydrostatic weighing equipment, air displacement plethysmography, and others. Bioimpedance analyzers are likely to hold the maximum market share in the global body composition analyzers market.

Based on mobility, body composition analyzers are divided into portable body composition analyzers and stationary body composition analyzers.

The end user segment of the market consists of hospitals, academic and research centers, fitness centers, home users, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are anticipated to hold the largest market share. The body composition analyzers market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. Increasing obesity in population, rising awareness about fitness, and technological advancements in the healthcare sector are likely to provide favorable conditions for the growth of the market during forecast period. 

The Asia-Pacific is anticipated to be the fastest growing market owing to the rising number of chronic disorders, well-established healthcare sectors, and increasing healthcare expenditure. The body composition analyzers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. According to the report published by International Diabetes Federation, in 2017, more than 72.94 million patients were affected by diabetes, this number represents 8.8% of the total population

The European body composition analyzers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The body composition analyzers market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Biobanking Market Size, Share, Growth Rate Analysis, Regional Trends and Forecast - 2030

Biobanking Market

The biobanking market size was valued USD 62.7 billion in 2021 and is expected to reach USD 98.1 billion by 2030 at 4.2% CAGR during the forecast period 2022-2030.

Market Drivers and Key Restraints

The global biobanking market is undergoing massive evolution in the form of technological innovations in genetic tools, which help elevate the demand for high-quality biospecimens used for enhancing cancer research. Citing a reference, Northwell Health had partnered with Indivumed in January 2017 for creating a cancer research biobank. In addition, the current developments in information technology as well as automation solutions have enhanced the efficiency of the biobanking services. For instance, with the launch of fully automated programmed freezers as well as refrigerators, the temperature monitoring in biobanks has become far more efficient than before.

Additionally, technological developments in biotechnology workflows have led to a growth in the application scope of biosamples. To illustrate, UK biobank had collaborated with GSK as well as Regeneron Genetics Center in March 2017, following which Regeneron had successfully sequenced all the 500,000 samples present in the UK biobank. These samples were highly instrumental in clinical research.

The noteworthy changes in the biobanking operations for ensuring optimization of sample maintenance and storage are expected to be one the prominent factors backing the growth of the market. These changes are inclusive of deposit and delivery of a sample in a temperature-monitored hatch along with automated tracking of the handling of a sample. Other significant changes include growth in funding, the increasing standardization of biobanking processes, and availability of collections that are centralized which are presumed to have a positive impact on the growth of the market.

Major Key Players:

Some of Biobanking Market Players are Hamilton Company, Greiner Holding AG, Promega Corporation, Becton Dickinson and Company, Merck KGaA, VWR Corporation, Tecan Trading AG, Thermo Fisher Scientific Inc., Panasonic Healthcare Holdings Co., Ltd, Qiagen N.V., Brooks Automation, Inc., Chart Industries, Inc., and others.

Segment Analysis

The global biobanking market is segmented on the basis of products and services, sample type, storage type, application, end-user, and region. Considering products and services, the market is segmented into equipment, consumables, services, and software. Equipment is further sub-segmented into storage equipment, sample analysis equipment, sample processing equipment, sample transport equipment, and others. Consumables are further sub-segmented into storage consumables, analysis consumables, processing consumables, collection consumables, and others. Services are sub-segmented into storage services, processing services, transport services, and supply services.

By sample type, the market is segmented into blood products, human tissues, cell lines, nucleic acids, biological fluids, and others. Based on storage type the market is segmented into manual storage and automated storage.

On the basis of application, the market is segmented into regenerative medicine, life science research, and clinical research.

By end-user, the market is segmented into hospitals, diagnostic laboratory, research centers, and others. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America.

Regional Analysis

The Americas dominates the global biobanking market owing to the increasing prevalence of chronic diseases and presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth.

Europe is the second largest in the global biobanking market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.

Asia Pacific is estimated to be the fastest growing market for biobanking. This can be attributed to the presence of developing economies such as India and China. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

On the other hand, the Middle East and Africa has the least share in the global biobanking market due to low per capita healthcare expenditure and stringent government policies, especially within the Africa region. It is estimated that the Middle East holds a majority of the market within the Middle Eastern and African region. 

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Catheter Securement Device Market Professional Survey and In-depth Analysis Research Report Foresight to 2030

Catheter Securement Device Market

The Catheter Securement Device Market is anticipated to reach USD 1,295.64 million by 2030 at 9.80% CAGR during the forecast period 2022-2030.

The global catheter securement device market is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period.

Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global catheter securement device market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (US) introduced the Hold-n-Place catheter securement device, which is soft, comfortable, and has a flexible design with no hard plastic parts. It provides complete antimicrobial protection.

Major Key Players:

Some of the Catheter Securement Device Market Players are 3M Company (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), C.R. Bard, Inc. (US), Centurion Medical Products (US), ConvaTec Group plc (UK), Merit Medical Systems, Inc. (US), Smiths Medical (US), TIDI Products, LLC (US), M.C. Johnson Company, Inc. (US), DeRoyal Industries, Inc. (US), Cardinal Health (US), BioDerm Inc. (US), Starboard Medical, Inc. (US), and Pepper Medical (US).

FREE SAMPLE

Segment Analysis

The global catheter securement device market has been segmented into product type, application, end user, and region.

By product type, the market has been segregated into arterial, central venous, peripheral, chest drainage tubes, abdominal drainage tubes, epidural, and all-site securement devices.

Central venous is further segmented intoperipherally inserted central catheter (PICC), subclavian, midlines, femoral, portal, and jugular.Peripheralis further segmented into foley catheter securement device, nasogastric tubes,endotracheal tubes,ventriculoperitoneal, and continuous nerve blocks. The abdominal drainage tubessegment is further segmented intopercutaneous endoscopic gastrostomy, jejunal, and umbilical. The peripheral securement devices segment held the majority share in 2020 due to the extensive use of peripheral securement devices for blood transfusions and the administration of intravenous fluids&other medications after surgery.

Based on application, the catheter securement device market is segmentedintocardiovascular,radiology, general surgery, urological, respiratory, and gastric&oropharyngeal.The cardiovascular segment held the largest share in 2020 due to the rising prevalence of cardiovascular disorders such asatrial septal defect, heart valve disease, and coronary artery diseaseacross the globe.

Based on end user, the catheter securement device market is segmented into hospitals & clinics, home healthcare, and diagnostic centers.The hospitals & clinics segment held the largest market share in 2020 due toalarge number of hospitals present across the globe anda vastnumber of surgical procedures performed across these facilities.

Regional Analysis

The market has been divided, by region, into North America, Europe, Asia-Pacific, and the Rest of the World. 

North America is likely to dominate thecatheter securement device market in 2020,owing to thehigh prevalence of chronic diseasesand the presence of major industry players across the region. In addition, a large number of foreign patients prefer surgical procedures to be conducted in the US due to the easyavailability of high-end advanced resources and well-established healthcare infrastructure. Furthermore, according to the Centers for Disease Control and Prevention (CDC), heart disease was the leading cause of death in the US from 2015 to 2020.Thus, the rising number of patients suffering from heart diseases in the USmay increase the demand forheart-related surgeries and procedures, which, in turn, is likely to increase the demandfor catheter securement devices.

Europe holds the second-largest position in the catheter securement device market due to the increased adoption of minimally invasive surgeries across the region. In addition, countries such as Germany, France, Italy, Spain, and the UK have a large number of aging population, supporting the growth of the catheter securement device market.

Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period due to increasing investment in healthcare infrastructure, improving healthcare facilities. High mortality rates due to chronic diseases such as heart diseases, respiratory diseases, urinary diseases, and diabetesare creating demand for catheter securement devices and driving the region's market growth.

The growth ofthe catheter securement device market in the Rest of the World is attributed to increasing public health awareness and government initiatives to bring more advanced technologies of catheter securement devicesinto the region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Surgical Instruments Market Players, Research Report and Forecast till 2030

Veterinary Surgical Instruments Market

The veterinary surgical instruments market size value is estimated to reach USD 2.76 billion, growing at a CAGR of 6.87% during the forecast period 2022-2030.

The industry of animal healthcare has seen strong technological advances in the last two decades. Most of these new tools and procedures have been adopted from human medical practice. These advanced technologies have not only led to better treatments, but also faster and precise diagnosis. From Ultrasounds and MRIs to the Amplatz Canine Ductal Occluder, there are various new technologies that are giving veterinary specialists a greater ability to diagnose and ultimately save sick animals globally. New technologies such as Magnetic resonance imaging, Ultrasounds, Laparoscopy, Microfracture detection, 3-D printing and Recombinant DNA.

While various veterinary technologies are likely to effect the industry in 2016, the biggest advancement is probable going to be the ability to print 3D objects, this rapid-prototyping procedure has been used by veterinary specialists to create animal bone models from information collected by computed tomography scans. This procedure not only helps veterinarians educate pet owners about their pet’s medical treatment or condition, but it also helps veterinary specialists to gain a solid understanding of a pets internal bone or muscle structure before going in to operate.

Major Key Players:

Veterinary surgical instruments Market Players are Eickemeyer Veterinary Equipment Inc., Jørgen KRUUSE A/S, Surgical Holdings, Sklar Instruments, Whittemore Enterprises, Inc., Medtronics, B.Braun and others.

Segment Analysis

The global veterinary surgical instruments market is segmented on the basis of type, application, animal type, and region.

By type, the global veterinary surgical instruments market is segmented into scalpel handles, forceps, dressing and tissue forceps, scissors, needle holders and retractors. The scissors segment holds a dominant 21.4% share in the global veterinary surgical instruments market and is expected to remain in the leading position over the forecast period due to the ubiquitous usage of scissors in surgical operations.

By application, the global veterinary surgical instruments market is segmented into sterilization, orthopedic, ophthalmic, and dental. Dental holds the largest share in the global veterinary surgical instruments market, followed by ophthalmic.

By animal type, the global veterinary surgical instruments market is segmented into canines, felines, and large animals.

Regional Analysis

Key markets for veterinary surgical instruments across the world include Asia Pacific/APAC, Middle East and Africa/MEA and North America along with Europe.

The US, one of the most developed countries in North America, is the world leader, as a result of the supportive reimbursement scenario along with the presence of a well-organized dairy and meat industry. The increasing efforts taken by the renowned firms to upgrade their product range, while ensuing top-quality standards helps foster the growth of the veterinary surgical instruments market in the region. The surge in pet insurance has also been favorable for the regional market in recent years. Reports by North American Pet Health Insurance Association reveal that over 2.5 million pets in Canada and US had insurance as of 2018.

The second lead has been procured by the European market, while South American countries like Paraguay, Uruguay and Argentina are also observing significant growth in the global market. Rising chronic disorder cases among animals have boosted surgical intervention and motivated the market growth in these areas.

However, the most promising market for veterinary surgical instruments is APAC, with China and India emerging as the leaders. Growth in pet humanization combined with the mounting awareness with regard to animal welfare can be cited as the top contributing factors to the market growth in Asia Pacific. Japan is one of the fast advancing markets in the region, since the country observes high adoption rate of modern techniques like new diagnostic services along with surging geriatric pet populace.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Menopause Treatment Market Research Report- Forecast till 2027

Menopause Treatment Market

Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms.

Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. 

For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry.

Major Key Players:

MRFR recognizes the following companies as the  Menopause Treatment Market Players are — Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US).

Segment Analysis

The global menopause treatment market is segmented based on treatment and distribution channel.

The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others.

Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores.

Regional Analysis

The global menopause market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology.  For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry.

The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market.

The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia.

The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com